QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q: What does CUSIP 74754R103 represent in this 13F holders report?

CUSIP 74754R103 is the security identifier for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q1 2021?

28 institutional investors reported QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 74754R103

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,138,804
Total 13F shares: 1,892,924
Share change: +645,564
Total reported value: $5,108,432
Put/Call ratio: 1095%
Price per share: $2.70
Number of holders: 28
Value change: +$1,699,282
Number of buys: 16
Number of sells: 8

Quarterly Holders Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 74754R103:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Top shareholders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	5.2%	317,818	$957,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	4.9%	301,195	$907,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2%	123,035	$370,000	—	31 Dec 2020	13F
QS Investors, LLC	13F	Company	1.3%	82,000	$247,000	—	31 Dec 2020	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	1%	62,500	$188,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.75%	45,928	$138,000	—	31 Dec 2020	13F
Cetera Investment Advisers	13F	Company	0.66%	40,275	$121,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.63%	38,731	$117,000	—	31 Dec 2020	13F
WEDBUSH SECURITIES INC	13F	Company	0.52%	32,228	$97,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.5%	30,533	$92,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.34%	20,824	$63,000	—	31 Dec 2020	13F
CRA Financial Services, LLC	13F	Company	0.33%	19,957	$60,000	—	31 Dec 2020	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.26%	15,800	$48,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	15,420	$47,000	—	31 Dec 2020	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.25%	15,197	$45,000	—	31 Dec 2020	13F
US BANCORP \DE\	13F	Company	0.16%	9,851	$29,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.1%	5,921	$18,000	—	31 Dec 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0.06%	3,602	$11,000	—	31 Dec 2020	13F
Retirement Group, LLC	13F	Company	0.04%	2,500	$7,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.04%	2,459	$7,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.04%	2,440	$7,000	—	31 Dec 2020	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.02%	1,000	$3,000	—	31 Dec 2020	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	791	$2,000	—	31 Dec 2020	13F
Your Advocates Ltd., LLP	13F	Company	0%	200	$1,000	—	31 Dec 2020	13F
Archer Investment Corp	13F	Company	0%	160	$482	—	31 Dec 2020	13F

Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q1 2021

As of 31 Mar 2021, QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,892,924 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, PRICE T ROWE ASSOCIATES INC /MD/, QS Investors, LLC, HighMark Wealth Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and HATTON CONSULTING, INC.. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.